# Continuing Enhanced National Surveillance for Prion Diseases in the United States

Source: https://welltoldgrants.com/grants/cdc-rfa-ck-27-0046-continuing-enhanced-national-surveillance-for-prion/  
Official notice: https://www.grants.gov/search-results-detail/363153

> Centers for Disease Control - NCEZID plans to offer grants of up to $25.0 million (at least $3.0 million) to any type of organization. It expects to make one award worth $25.0 million in total. It is a forecast: the notice is expected around December 29, 2026, with applications due around March 27, 2027.

| Field | Value |
|---|---|
| Opportunity number | CDC-RFA-CK-27-0046 |
| Agency | Centers for Disease Control - NCEZID |
| Status | Forecast |
| Deadline | expected March 27, 2027 |
| Award ceiling | $25.0 million |
| Award floor | $3.0 million |
| Expected awards | 1 |
| Total funding | $25.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.317 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The CDC announces the availability of FY 2027 funds for a cooperative agreement to continue enhanced national surveillance for human prion diseases, also known as transmissible spongiform encephalopathies (TSEs), in the United States. The purpose is to continue an active surveillance program to help confirm suspected and clinically diagnosed cases of human prion disease and to monitor the occurrence of potentially emerging human prion diseases in the United States. Outcomes are enhanced national surveillance for always fatal human prion diseases through improved diagnoses and continued monitoring for emerging or new prion diseases in the United States. These outcomes are accomplished through the funding of a specialized center to conduct state-of-the-art diagnostic techniques. Prion diseases can only be confirmed through brain tissue analyses, and many facilities lack the expertise and/or the willingness, due to infection control concerns, to handle and accurately diagnose specimens from suspected cases. Since 1997, the Centers for Disease Control and Prevention (CDC) has funded a center to provide prion disease diagnostic services, which has allowed for disease confirmation, evaluation of disease trends over time, and identification of disease subtypes. Data have been shared with CDC experts who partner with center staff, providing guidance and epidemiological knowledge. This collaboration has contributed to accurate national surveillance findings and helped to provide confidence that novel prion diseases, such as a human form of the animal prion disease, chronic wasting disease, have not been occurring in the country.

## Questions people ask

### Who can apply for Continuing Enhanced National Surveillance for Prion Diseases in the United States?

Centers for Disease Control - NCEZID accepts applications from any type of organization.

### What is the deadline for Continuing Enhanced National Surveillance for Prion Diseases in the United States?

Expected deadline March 27, 2027. Confirm the date and time in the official notice on Grants.gov.

### How much funding is available?

Awards of up to $25.0 million each. About $25.0 million in total for one award.